1.
Iannazzo S, Santoni L, Saleri C, et al. [Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways. 2016;17(2S):37-48. https://doi.org/10.7175/fe.v17i2S.1231